Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
Get Insiders for : 
Disc Medicine, Inc (IRON)  
$48.05 0.00 (0.00%) as of 4:30 Thu 9/26


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 29,730,000
Market Cap: 1.43(B)
Last Volume: 0 Avg Vol: 0
52 Week Range: $26.52 - $75.32
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:

   

Rankings:

     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Gemeni Therapeutics is a clinical-stage precision medicine company developing therapeutic compounds to treat genetically defined, age-related macular degeneration (AMD). Co.'s lead product candidate, GEM103, is a recombinant form of the human complement factor H protein and is designed to address complement hyperactivity and overall dysregulation caused by loss of function mutations thus restoring retinal health in patients with AMD.


 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 388,891 388,891 1,041,066
Total Buy Value $0 $14,000,076 $14,000,076 $29,000,101
Total People Bought 0 3 3 4
Total Buy Transactions 0 3 3 6
Total Shares Sold 5,359 7,718 1,816,962 3,929,884
Total Sell Value $263,201 $348,817 $108,643,672 $210,504,498
Total People Sold 2 2 9 13
Total Sell Transactions 5 8 41 60
End Date 2024-07-21 2024-04-19 2023-10-20 2022-10-20

   
Records found: 101
  Page 1 of 5  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

 
3m +/-  
Form
   Blavatnik Len   –       –       •   2024-06-17 4 A $36.00 $15,000,012 D/D 416,667 3,558,426     -
   Ashiya Mona Director   –       •      –    2024-06-17 4 B $36.00 $3,000,024 I/I 83,334 235,391 2.1 13%     
   Orbimed Genesis Gp Llc Director   –       •      –    2024-06-17 4 B $36.00 $3,000,024 I/I 83,334 235,391 2.1 13%     
   Bitterman Kevin   –       •      –    2024-06-17 4 B $36.00 $8,000,028 I/I 222,223 420,549 0.01 13%     
   White William Richard   –       •      –    2024-06-03 4 AS $35.15 $70,608 D/D (1,957) 0 33%     
   White William Richard   –       •      –    2024-06-03 4 OE $2.65 $6,635 D/D 1,957 1,957     -
   White William Richard   –       •      –    2024-05-01 4 AS $28.52 $5,755 D/D (201) 0 70%     
   White William Richard   –       •      –    2024-05-01 4 OE $9.86 $1,982 D/D 201 201     -
   White William Richard   –       •      –    2024-04-11 4 AS $31.79 $81,407 D/D (2,560) 0 52%     
   White William Richard   –       •      –    2024-04-11 4 OE $2.65 $12,581 D/D 2,560 2,560     -
   Savage William Jacob Chief Medical Officer   •       –      –    2024-04-10 4 OE $2.65 $57,956 D/D 21,870 43,405     -
   Bitterman Kevin   –       •      –    2024-03-05 4 S $73.50 $1,922,540 I/I (26,157) 677,503 31%     
   Stephenson Pamela Chief Commercial Officer   •       –      –    2024-02-26 4 A $0.00 $0 D/D 36,666 36,666     -
   Franchi Jean M. Chief Financial Officer   •       –      –    2024-02-07 4 A $0.00 $0 D/D 36,666 36,666     -
   Atlas Venture Associates Opportunity Ii, Llc 10% Owner   –       –       •   2024-01-23 4 S $67.65 $6,934,125 I/I (102,500) 198,326 45%     
   Atlas Venture Associates Opportunity Ii, Llc 10% Owner   –       –       •   2024-01-23 4 S $67.65 $3,213,375 D/D (47,500) 1,402,186 45%     
   Bitterman Kevin Director   –       •      –    2024-01-23 4 S $67.65 $6,934,125 I/I (102,500) 198,326 45%     
   Yu Jonathan Yen-Wen Chief Business Officer   •       –      –    2024-01-10 4 A $0.00 $0 D/D 18,165 18,165     -
   Savage William Jacob Chief Medical Officer   •       –      –    2024-01-10 4 A $0.00 $0 D/D 18,535 21,535     -
   Bryce Joanne Chief Financial Officer   •       –      –    2024-01-10 4 A $0.00 $0 D/D 18,165 23,665     -
   Quisel John D Chief Executive Officer   •       •      –    2024-01-10 4 A $0.00 $0 D/D 66,365 69,065     -
   Khara Rahul General Counsel   •       –      –    2024-01-10 4 A $0.00 $0 D/D 14,035 14,035     -
   Atlas Venture Associates Opportunity I, Llc 10% Owner   –       –       •   2024-01-10 4 S $64.00 $1,280,000 I/I (20,000) 786,160 51%     
   Atlas Venture Associates Opportunity I, Llc 10% Owner   –       –       •   2024-01-10 4 S $64.00 $1,920,000 D/D (30,000) 1,449,686 51%     
   Bitterman Kevin Director   –       •      –    2024-01-10 4 S $64.00 $1,280,000 I/I (20,000) 786,160 51%     

  101 Records found
  1  2  3  4  5   
  Page 1 of 5
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed